Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance

Area of Science:

• Cardiology
• Geriatrics
• Neurology

Background:

• Atrial fibrillation management guidelines recommend anticoagulation for most patients aged 65 and older.
• However, up to 50% of elderly patients with atrial fibrillation do not receive this crucial therapy in clinical practice.

Purpose of the Study:

• To investigate the reasons behind the underutilization of anticoagulation in older patients with atrial fibrillation.
• To address the perceived high risk of falls and bleeding, particularly intracranial hemorrhage, as a barrier to treatment.

Main Methods:

• Review of clinical practice patterns and physician-reported reasons for withholding anticoagulation.
• Analysis of guideline recommendations versus real-world application in elderly populations.

Main Results:

• Physicians frequently cite fear of falls and subsequent bleeding, including intracranial hemorrhage, as the primary reason for not prescribing anticoagulation.
• A significant gap exists between guideline recommendations and the actual treatment of older atrial fibrillation patients.

Conclusions:

• Physician perception of bleeding risk significantly impacts anticoagulation decisions in elderly atrial fibrillation patients.
• Further research and clinical strategies are needed to overcome these barriers and ensure appropriate stroke prevention.